KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,416,724 | +0.6% | 460,489 | +1.8% | 1.72% | +8.5% |
| Q2 2023 | $53,118,000 | +48.3% | 452,456 | +1.1% | 1.58% | +36.3% |
| Q1 2023 | $35,818,000 | +5.9% | 447,393 | +4.8% | 1.16% | -5.6% |
| Q4 2022 | $33,817,354 | +16.4% | 426,879 | +2.4% | 1.23% | +10.6% |
| Q3 2022 | $29,048,000 | +8.2% | 416,756 | +1.9% | 1.11% | +4.1% |
| Q2 2022 | $26,856,000 | +4.9% | 409,011 | +6.3% | 1.07% | +25.4% |
| Q1 2022 | $25,605,000 | +62.2% | 384,810 | +70.5% | 0.85% | +79.9% |
| Q4 2021 | $15,790,000 | +33.9% | 225,727 | -0.1% | 0.47% | +29.6% |
| Q3 2021 | $11,794,000 | -26.1% | 225,901 | -3.8% | 0.36% | -23.2% |
| Q2 2021 | $15,964,000 | -12.9% | 234,767 | -1.3% | 0.48% | -19.4% |
| Q1 2021 | $18,326,000 | +17.0% | 237,882 | -8.9% | 0.59% | +13.5% |
| Q4 2020 | $15,667,000 | +41.5% | 261,122 | +1.5% | 0.52% | +7.9% |
| Q3 2020 | $11,073,000 | -5.3% | 257,203 | -8.9% | 0.48% | -8.2% |
| Q2 2020 | $11,689,000 | – | 282,211 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $53,700,000 | 4.14% |
| S Squared Technology, LLC | 85,215 | $5,113,000 | 2.93% |
| First Light Asset Management, LLC | 491,740 | $29,504,000 | 2.18% |
| Redmile Group, LLC | 1,675,036 | $100,502,000 | 1.22% |
| Nicholas Investment Partners, LP | 233,543 | $14,013,000 | 1.08% |
| HighMark Wealth Management LLC | 17,586 | $1,055,000 | 0.91% |
| DSAM Partners (London) Ltd | 87,608 | $5,256,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 101,044 | $6,063,000 | 0.54% |
| Hood River Capital Management LLC | 261,122 | $15,667,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 9,900 | $594,000 | 0.45% |